TIMEInside the Controversy Around Biogen's Alzheimer's Drug, Aduhelm | TIMEAug 5, 2021Alice Park & Tara LawBy Alice Park & Tara Lawmore_vert
STATFederal watchdog will review the controversial FDA approval of Biogen's Alzheimer's drugAug 4, 2021Ed SilvermanBy Ed Silvermanmore_vert
Full CoverageFull Coverage
